MITOQUINONE IMPROVES MITOCHONDRIAL FUNCTION BUT DOES NOT PREVENT ROTENONE-INDUCED NEURONAL AND SYNAPTIC DEFICITS
University of Sao Paulo
Presentation
Date TBA
Event Information
Poster Board
PS01-07AM-485
Poster
View posterAbstract
Recommended posters
THE MITOCHONDRIAL TARGETED ANTIOXIDANT MITOQ PREVENTS COGNITIVE DECLINE IN A NEURODEVELOPMENTAL DISORDER MODEL IN RATS
Isabel Faulkner, Elizabeth Broadbent, Jocelyn Glazier, Michael Harte, Reinmar Hager
TARGETING THE MITOCHONDRIAL QUALITY CONTROL IN MODELS OF NEURODEVELOPMENTAL DISORDERS BASED ON BRAIN-ENVIRONMENT INTERACTION
Laura Norma, Tiziana Imbriglio, Milena Cannella, Giovanni Sebastiano Alemà, Luisa Di Menna, Valeria Bruno, Stefania Maccari, Ferdinando Nicoletti, Giuseppe Battaglia, Rosamaria Orlando
RESTORATION OF NADH OXIDATION IN DOPAMINERGIC NEURONS PREVENTS PARKINSONISM
Esther García Benítez, Karis B D’Alessandro, Alejandro Jiménez-Medina, Enrico Zampese, Xavier d’Anglemont de Tassigny, Claudia García-Rodríguez, James Surmeier, José López-Barneo, Patricia González-Rodríguez
MODULATION OF NEUROTROPHIC SIGNALING PATHWAYS IN NEURONAL DYSFUNCTION ASSOCIATED WITH PARKINSON’S DISEASE
Daniele Pensabene, Noemi Martella, Michela Varone, Emanuele Bisesto, Mayra Colardo, Sandra Moreno, Marco Segatto
SUSCEPTIBILITY OF DOPAMINERGIC NERVE TERMINALS TO MITOCHONDRIAL DYSFUNCTION
Maya Faour, Nelson Rebola, Jaime De Juan-Sanz
CHARACTERIZATION OF NOGO-A–MEDIATED MECHANISMS UNDERLYING DOPAMINERGIC AND MITOCHONDRIAL DYSREGULATION IN AN IPSC-DERIVED PARKINSON’S DISEASE MODEL
Sara Alonso Jiménez, Rouaa Ben Chaabene, Angélique Ducray, Meike Mevissen